Skip to Content

TEMOZOLOMIDE 180 mg (Temozolomide 180 mg)

Pill with imprint TEMOZOLOMIDE 180 mg is Brown & White, Capsule-shape and has been identified as Temozolomide 180 mg. It is supplied by IDT Australia Limited.

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma; anaplastic oligodendroglioma; melanoma, metastatic; melanoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEMOZOLOMIDE 180 mg

Temozolomide 180 mg TEMOZOLOMIDE 180 mg

Temozolomide

Imprint:
TEMOZOLOMIDE 180 mg
Strength:
180 mg
Color:
Brown & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Alkylating agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
IDT Australia Limited
National Drug Code (NDC):
64144-0505

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide